BI
The startup has developed a synthetic chemistry platform that generates novel pharmacophores and drug modalities to meet unmet therapeutic needs. Its technology enhances sustainable farming by producing a compound that minimizes fungicide resistance and reduces chemical applications while maintaining efficacy.
Updated 18 months ago
Funding
$45M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
NIFunding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup has developed a synthetic chemistry platform that generates novel pharmacophores and drug modalities to meet unmet therapeutic needs. Its technology enhances sustainable farming by producing a compound that minimizes fungicide resistance and reduces chemical applications while maintaining efficacy.